← SynDRA
NI-57
SynDRA canonical compound SYN0058935 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | BRD1 | BRPF1 | BRPF3 |
|---|
| Mechanism of action | bromodomain inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- BRPF1 BINDER
- BRPF3 BINDER
- BRD1 BINDER
- BET bromodomain inhibitor
- BRD1 INHIBITOR
- BRPF1 INHIBITOR
- BRPF3 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- GTPL8573
- NI 57
- CHEMBL3752151
- 4-Cyano-~{n}-(1,3-Dimethyl-2-Oxidanylidene-Quinolin-6-Yl)-2-Methoxy-Benzenesulfonamide
- SCHEMBL17560720
- MolPort-039-101-322
- EX-A1876
- BDBM50157570
- ZINC254286814
- AKOS027470204
- NCGC00483115-01
- NI-57, >
- HY-19537
- CS-0015636
- 4-cyano-N-(1,3-dimethyl-2-oxoquinolin-6-yl)-2-methoxybenzenesulfonamide
- 4-cyano-N-(1,3-dimethyl-2-oxo-1,2-dihydroquinolin-6-yl)-2-methoxybenzenesulfonamide
- RefChem:853807
- MFCD29081191
- orb1296217
- SCHEMBL29823517
- GLXC-07026
- EBC-50058
- NI-57?
- NSC782391
- NSC-782391
- AC-35729
- BN166032
- BP-25365
- DA-66082
- MS-26293
- NI-57, >=98% (HPLC)
- G14616
- EN300-26188950
- Z2204991787
- LS8
Look up NI-57 in the interactive SynDRA portal →